These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30879920)

  • 21. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
    Xu M; Zheng XM; Jiang F; Qiu WQ
    J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance.
    Xu E; Dubois MJ; Leung N; Charbonneau A; Turbide C; Avramoglu RK; DeMarte L; Elchebly M; Streichert T; Lévy E; Beauchemin N; Marette A
    Endocrinology; 2009 Aug; 150(8):3503-12. PubMed ID: 19406938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver-Specific Deletion of Mouse CTCF Leads to Hepatic Steatosis via Augmented PPARγ Signaling.
    Choi Y; Song MJ; Jung WJ; Jeong H; Park S; Yang B; Lee EC; Joo JS; Choi D; Koo SH; Kim EK; Nam KT; Kim HP
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1761-1787. PubMed ID: 34358714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of thioesterase superfamily member 2 in skeletal muscle promotes hepatic steatosis and insulin resistance in mice.
    Imai N; Nicholls HT; Alves-Bezerra M; Li Y; Ivanova AA; Ortlund EA; Cohen DE
    Hepatology; 2022 Jan; 75(1):154-169. PubMed ID: 34433228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemin Improves Insulin Sensitivity and Lipid Metabolism in Cultured Hepatocytes and Mice Fed a High-Fat Diet.
    Luan Y; Zhang F; Cheng Y; Liu J; Huang R; Yan M; Wang Y; He Z; Lai H; Wang H; Ying H; Guo F; Zhai Q
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
    Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
    J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
    Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
    Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
    Item F; Wueest S; Lemos V; Stein S; Lucchini FC; Denzler R; Fisser MC; Challa TD; Pirinen E; Kim Y; Hemmi S; Gulbins E; Gross A; O'Reilly LA; Stoffel M; Auwerx J; Konrad D
    Nat Commun; 2017 Sep; 8(1):480. PubMed ID: 28883393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
    Lu Y; Jiang Z; Dai H; Miao R; Shu J; Gu H; Liu X; Huang Z; Yang G; Chen AF; Yuan H; Li Y; Cai J
    Hepatology; 2018 Apr; 67(4):1303-1319. PubMed ID: 29091299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCTP participates in hepatic metabolism by regulating gene expression involved in insulin resistance.
    Dong K; Zhao Q; Xue Y; Wei Y; Zhang Y; Yang Y
    Gene; 2021 Feb; 768():145263. PubMed ID: 33122078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD.
    Ashworth WB; Davies NA; Bogle ID
    PLoS Comput Biol; 2016 Sep; 12(9):e1005105. PubMed ID: 27632189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease.
    Pei E; Liu Y; Jiang W; Lin S; Huang L; Lin M; Cai L
    Lipids Health Dis; 2018 Oct; 17(1):243. PubMed ID: 30355361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
    Zheng F; Cai Y
    Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.